These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 15901795

  • 21. The pore region of N-methyl-D-aspartate receptors differentially influences stimulation and block by spermine.
    Jin L, Miyazaki M, Mizuno S, Takigawa M, Hirose T, Nishimura K, Toida T, Williams K, Kashiwagi K, Igarashi K.
    J Pharmacol Exp Ther; 2008 Oct; 327(1):68-77. PubMed ID: 18632991
    [Abstract] [Full Text] [Related]

  • 22. Structure-activity relationships of pentacycloundecylamines at the N-methyl-d-aspartate receptor.
    Geldenhuys WJ, Malan SF, Bloomquist JR, Van der Schyf CJ.
    Bioorg Med Chem; 2007 Feb 01; 15(3):1525-32. PubMed ID: 17157509
    [Abstract] [Full Text] [Related]

  • 23. Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore.
    Kashiwagi K, Masuko T, Nguyen CD, Kuno T, Tanaka I, Igarashi K, Williams K.
    Mol Pharmacol; 2002 Mar 01; 61(3):533-45. PubMed ID: 11854433
    [Abstract] [Full Text] [Related]

  • 24. Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARs.
    Otton HJ, Lawson McLean A, Pannozzo MA, Davies CH, Wyllie DJ.
    Neuropharmacology; 2011 Mar 01; 60(2-3):388-96. PubMed ID: 20955720
    [Abstract] [Full Text] [Related]

  • 25. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
    Peeters M, Gunthorpe MJ, Strijbos PJ, Goldsmith P, Upton N, James MF.
    J Pharmacol Exp Ther; 2007 May 01; 321(2):564-72. PubMed ID: 17267580
    [Abstract] [Full Text] [Related]

  • 26. The NR1 M3 domain mediates allosteric coupling in the N-methyl-D-aspartate receptor.
    Blanke ML, VanDongen AM.
    Mol Pharmacol; 2008 Aug 01; 74(2):454-65. PubMed ID: 18483226
    [Abstract] [Full Text] [Related]

  • 27. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
    Volbracht C, van Beek J, Zhu C, Blomgren K, Leist M.
    Eur J Neurosci; 2006 May 01; 23(10):2611-22. PubMed ID: 16817864
    [Abstract] [Full Text] [Related]

  • 28. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
    Hirbec H, Mausset AL, Kamenka JM, Privat A, Vignon J.
    J Neurosci Res; 2002 May 01; 68(3):305-14. PubMed ID: 12111860
    [Abstract] [Full Text] [Related]

  • 29. Different structural requirements for functional ion pore transplantation suggest different gating mechanisms of NMDA and kainate receptors.
    Villmann C, Hoffmann J, Werner M, Kott S, Strutz-Seebohm N, Nilsson T, Hollmann M.
    J Neurochem; 2008 Oct 01; 107(2):453-65. PubMed ID: 18710418
    [Abstract] [Full Text] [Related]

  • 30. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X, Marszalec W, Toth PT, Huang J, Yeh JZ, Narahashi T.
    Neuropharmacology; 2006 Dec 01; 51(7-8):1181-91. PubMed ID: 17011596
    [Abstract] [Full Text] [Related]

  • 31. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism.
    Chen HS, Lipton SA.
    J Physiol; 1997 Feb 15; 499 ( Pt 1)(Pt 1):27-46. PubMed ID: 9061638
    [Abstract] [Full Text] [Related]

  • 32. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
    Lipton SA.
    Curr Alzheimer Res; 2005 Apr 15; 2(2):155-65. PubMed ID: 15974913
    [Abstract] [Full Text] [Related]

  • 33. NR3A modulates the outer vestibule of the "NMDA" receptor channel.
    Wada A, Takahashi H, Lipton SA, Chen HS.
    J Neurosci; 2006 Dec 20; 26(51):13156-66. PubMed ID: 17182766
    [Abstract] [Full Text] [Related]

  • 34. NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterization.
    Danysz W, Parsons CG, Quack G.
    Amino Acids; 2000 Dec 20; 19(1):167-72. PubMed ID: 11026485
    [Abstract] [Full Text] [Related]

  • 35. Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons.
    Maler JM, Esselmann H, Wiltfang J, Kunz N, Lewczuk P, Reulbach U, Bleich S, Rüther E, Kornhuber J.
    Brain Res; 2005 Aug 09; 1052(2):156-62. PubMed ID: 16009352
    [Abstract] [Full Text] [Related]

  • 36. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL.
    IDrugs; 2005 Mar 09; 8(3):229-35. PubMed ID: 15772895
    [Abstract] [Full Text] [Related]

  • 37. Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.
    Kotermanski SE, Johnson JW.
    J Neurosci; 2009 Mar 04; 29(9):2774-9. PubMed ID: 19261873
    [Abstract] [Full Text] [Related]

  • 38. Probing the Mg2+ blockade site of an N-methyl-D-aspartate (NMDA) receptor with unnatural amino acid mutagenesis.
    McMenimen KA, Dougherty DA, Lester HA, Petersson EJ.
    ACS Chem Biol; 2006 May 23; 1(4):227-34. PubMed ID: 17163677
    [Abstract] [Full Text] [Related]

  • 39. Differential contribution of the NR1- and NR2A-subunits to the selectivity filter of recombinant NMDA receptor channels.
    Wollmuth LP, Kuner T, Seeburg PH, Sakmann B.
    J Physiol; 1996 Mar 15; 491 ( Pt 3)(Pt 3):779-97. PubMed ID: 8815211
    [Abstract] [Full Text] [Related]

  • 40. N1-dansyl-spermine and N1-(n-octanesulfonyl)-spermine, novel glutamate receptor antagonists: block and permeation of N-methyl-D-aspartate receptors.
    Chao J, Seiler N, Renault J, Kashiwagi K, Masuko T, Igarashi K, Williams K.
    Mol Pharmacol; 1997 May 15; 51(5):861-71. PubMed ID: 9145925
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.